Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ImmuPharma plc (GB:IMM)
:IMM
Holding GB:IMM?
Track your performance easily
IMM Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.82p - 4.90p
Previous CloseN/A
Volume11.77M
Average Volume (3M)9.29M
Market Cap
£10.93M
Enterprise Value7.58M
Total Cash (Recent Filing)$1.88M
Total Debt (Recent Filing)$219.44K
Price to Earnings (P/E)―
Beta0.57
Next Earnings
May 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding416,437,260
10 Day Avg. Volume24,984,277
30 Day Avg. Volume9,292,877
Standard Deviation0.23
R-Squared0.17
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)199.41
Price to Cash Flow (P/CF)-11.30
P/FCF Ratio0.00
Enterprise Value/Market Cap0.69
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ImmuPharma News
PremiumCompany Announcements
ImmuPharma Unveils Breakthrough in Autoimmune Disease Research
PremiumCompany Announcements
ImmuPharma Targets Global Partnerships at Key Biotech Events
PremiumCompany Announcements
ImmuPharma Appoints New Auditor, Crowe LLPPremiumCompany Announcements
ImmuPharma Appoints New Auditor Crowe LLP
PremiumCompany Announcements
Immupharma Announces Change in Major Shareholdings
PremiumCompany Announcements
ImmuPharma Strengthens Financial Team with New Appointment
PremiumCompany Announcements
ImmuPharma Appoints New Company Secretary for Strategic Growth
PremiumCompany Announcements
ImmuPharma Extends Incanthera Warrants to 2025IMM FAQ
What was ImmuPharma plc’s price range in the past 12 months?
ImmuPharma plc lowest share price was 0.82p and its highest was 4.90p in the past 12 months.
What is ImmuPharma plc’s market cap?
ImmuPharma plc’s market cap is £10.93M.
When is ImmuPharma plc’s upcoming earnings report date?
ImmuPharma plc’s upcoming earnings report date is May 22, 2025 which is in 123 days.
How were ImmuPharma plc’s earnings last quarter?
ImmuPharma plc released its earnings results on Sep 09, 2024. The company reported -0.001p earnings per share for the quarter, missing the consensus estimate of N/A by -0.001p.
Is ImmuPharma plc overvalued?
According to Wall Street analysts ImmuPharma plc’s price is currently Overvalued.
Does ImmuPharma plc pay dividends?
ImmuPharma plc does not currently pay dividends.
What is ImmuPharma plc’s EPS estimate?
ImmuPharma plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ImmuPharma plc have?
ImmuPharma plc has 416,437,260 shares outstanding.
What happened to ImmuPharma plc’s price movement after its last earnings report?
ImmuPharma plc reported an EPS of -0.001p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.247%.
Which hedge fund is a major shareholder of ImmuPharma plc?
Currently, no hedge funds are holding shares in GB:IMM
---
Company Description
ImmuPharma plc
ImmuPharma PLC is a drug discovery and development company. The company is focused on the development of drugs based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. It has drug candidates in development, over two platform technologies and approximately 70 patents. Lupuzor is the company's drug candidate and is a treatment for lupus, and life-threatening autoimmune disease. The company's pipeline includes novel peptide-based therapeutics within four therapy areas: Autoimmunity; Anti-Infectives; Metabolism and Cancer.
---
Technical Analysis
Sareum Holdings
―
Scancell Holdings
―
ValiRx plc
―
Open Orphan Plc
―
Ovoca Gold
―
Akanda Corp
―
---